GlassScriptPhysician profile
Timothy M Wirth
NPI 1396741765
$692.71
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $131.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $93.58 | 2019 | |
| Novo Nordisk INC | $82.04 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $80.73 | 2019-2020 | |
| Glaxosmithkline, LLC. | $66.21 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.24 | 2019-2020 | |
| Lilly USA, LLC | $39.95 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $38.31 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $38.02 | 2019-2020 | |
| Allergan, INC. | $37.12 | 2020 | |
| Pfizer INC. | $32.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.39 | 2019 | |
| Abbott Laboratories | $21.13 | 2019 | |
| Astellas Pharma US INC | $16.20 | 2019 | |
| Sanofi Pasteur INC. | $16.04 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.81 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $13.85 | 2019 | |
| Merck Sharp & Dohme LLC | $11.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Wirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.